- In April 2023, STERIS Corporation announced the launch of its next-generation self-sterilizing surgical instrument line, integrating advanced UV-C and antimicrobial coating technologies to automatically maintain sterility during extended procedures. This innovation is aimed at reducing surgical site infections (SSIs) and improving operating room efficiency across high-volume hospitals in North America and Europe
- In March 2023, Olympus Corporation introduced a self-sterilizing endoscope series, featuring built-in ozone-based sterilization modules that eliminate up to 99.9% of pathogens between uses. The development is part of Olympus’s broader strategy to support infection control compliance and operational turnaround in ambulatory surgical centers
- In March 2023, 3M Health Care partnered with a network of hospitals in Southeast Asia to pilot its antimicrobial-coated wearable sensors. These devices, designed for remote patient monitoring, leverage nano-silver technologies to provide continuous protection against microbial contamination, thus reducing the burden on traditional sterilization methods in resource-constrained settings
- In February 2023, Medtronic plc unveiled a self-sterilizing catheter prototype incorporating steam-based sterilization chambers activated post-procedure. This solution targets intensive care and interventional cardiology use, aiming to minimize infection risks and reduce reliance on external sterilization services
- In January 2023, BD (Becton, Dickinson and Company) announced regulatory clearance for its self-sterilizing infusion port system, which uses integrated UV-C light mechanisms to sanitize the port site between infusions. The technology aims to enhance safety in oncology and dialysis treatment environments, where infection control is critical
